Evidence mapPaperPMID 42352504Full record

ReviewCancers2026

Cytokine-STAT3 Signaling Axis in Clear Cell Renal Cell Carcinoma: Implications for Tumor Microenvironment and Biomarker Discovery.

Martina Šutovská, Matúš Dohál, Eduard Gondáš, Jozef Mažerik, Ján Švihra, Lucia Cipková, Soňa Fraňová, Ján Ľupták

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Martina ŠutovskáDepartment of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Malá Hora 10701/4A, 03601 Martin, Slovakia.ORCID 0000-0003-1826-0786
Matúš DohálDepartment of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Malá Hora 10701/4A, 03601 Martin, Slovakia.
Eduard GondášDepartment of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Malá Hora 10701/4A, 03601 Martin, Slovakia.
Jozef MažerikDepartment of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Malá Hora 10701/4A, 03601 Martin, Slovakia.
Ján ŠvihraUrology Clinic, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital Martin, Kollárova 2, 03659 Martin, Slovakia.ORCID 0000-0001-6271-0583
Lucia CipkováDepartment of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Malá Hora 10701/4A, 03601 Martin, Slovakia.
Soňa FraňováDepartment of Pharmacology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Malá Hora 10701/4A, 03601 Martin, Slovakia.
Ján ĽuptákUrology Clinic, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital Martin, Kollárova 2, 03659 Martin, Slovakia.ORCID 0000-0002-9131-7753

Funding

Ministry of Education, Science, Research and Sport of the Slovak Republic 1/0072/23Slovak Research and Development Agency (APVV) APVV-19-0033
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clear cell renal cell carcinomacytokinesinflammationSTAT3 signalingtranslational oncologytumor microenvironmenturinary biomarkers

Identifiers

PMID42352504
PMCPMC13296401

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.